$1.11 Billion is the total value of Redmile Group, LLC's 54 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Buy | ARRAY BIOPHARMA INC | $96,736,000 | +72.5% | 13,125,594 | +10.7% | 8.69% | +42.2% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $66,872,000 | +65.5% | 900,879 | +24.8% | 6.00% | +36.5% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $63,455,000 | +10.9% | 5,832,228 | -15.2% | 5.70% | -8.5% |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $53,333,000 | +10.1% | 268,519 | -20.7% | 4.79% | -9.2% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $53,203,000 | – | 853,973 | +100.0% | 4.78% | – |
| ENDP | New | ENDO INTL PLC | $50,272,000 | – | 560,443 | +100.0% | 4.51% | – |
| ASPX | New | AUSPEX PHARMACEUTICALS INC | $41,866,000 | – | 417,533 | +100.0% | 3.76% | – |
| BIIB | Buy | BIOGEN INC | $41,258,000 | +181.9% | 97,713 | +126.6% | 3.70% | +132.5% |
| SGEN | Buy | SEATTLE GENETICS INC | $37,212,000 | +17.7% | 1,052,666 | +7.0% | 3.34% | -2.9% |
| ALR | New | ALERE INC | $32,476,000 | – | 664,138 | +100.0% | 2.92% | – |
| CMRX | Sell | CHIMERIX INC | $31,828,000 | -31.7% | 844,456 | -27.0% | 2.86% | -43.7% |
| INSM | Buy | INSMED INC | $28,742,000 | +83.5% | 1,381,828 | +36.5% | 2.58% | +51.4% |
| RCPT | Sell | RECEPTOS INC | $26,286,000 | -31.4% | 159,413 | -49.0% | 2.36% | -43.4% |
| FLDM | Sell | FLUIDIGM CORP DEL | $23,679,000 | +15.0% | 562,437 | -7.9% | 2.13% | -5.2% |
| AET | New | AETNA INC NEW | $22,582,000 | – | 211,974 | +100.0% | 2.03% | – |
| DVA | New | DAVITA HEALTHCARE PARTNERS I | $21,609,000 | – | 265,858 | +100.0% | 1.94% | – |
| HWAY | Buy | HEALTHWAYS INC | $21,158,000 | -0.4% | 1,074,033 | +0.5% | 1.90% | -17.9% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $20,651,000 | – | 332,600 | +100.0% | 1.85% | – |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $19,930,000 | +36.6% | 1,415,482 | +32.2% | 1.79% | +12.7% |
| CIVI | CIVITAS SOLUTIONS INC | $18,416,000 | +23.0% | 879,485 | 0.0% | 1.65% | +1.4% | |
| CSLT | Buy | CASTLIGHT HEALTH INCcl b | $18,131,000 | +24.2% | 2,336,498 | +87.3% | 1.63% | +2.5% |
| MODN | MODEL N INC | $17,482,000 | +12.6% | 1,461,678 | 0.0% | 1.57% | -7.1% | |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $17,279,000 | – | 100,000 | +100.0% | 1.55% | – |
| ZSPH | Sell | ZS PHARMA INC | $17,071,000 | -21.7% | 405,688 | -22.7% | 1.53% | -35.5% |
| AAVL | Sell | AVALANCHE BIOTECHNOLOGIES IN | $17,064,000 | -54.8% | 421,133 | -39.8% | 1.53% | -62.7% |
| WOOF | New | VCA INC | $16,874,000 | – | 307,804 | +100.0% | 1.52% | – |
| TRIV | Sell | TRIVASCULAR TECHNOLOGIES INC | $16,665,000 | -24.5% | 1,588,623 | -9.5% | 1.50% | -37.7% |
| PRQR | PROQR THRAPEUTICS N V | $16,436,000 | +4.5% | 751,171 | 0.0% | 1.48% | -13.8% | |
| HNT | Sell | HEALTH NET INC | $16,354,000 | -1.1% | 270,358 | -12.5% | 1.47% | -18.5% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $15,968,000 | -8.7% | 668,671 | -32.5% | 1.43% | -24.7% |
| GMED | GLOBUS MED INCcl a | $15,440,000 | +6.2% | 611,731 | 0.0% | 1.39% | -12.4% | |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $15,245,000 | +3102.7% | 547,000 | +1995.8% | 1.37% | +2532.7% |
| ARAY | Sell | ACCURAY INC | $14,094,000 | +21.6% | 1,515,475 | -1.3% | 1.26% | +0.2% |
| TKMR | New | TEKMIRA PHARMACEUTICALS CORP | $12,222,000 | – | 700,000 | +100.0% | 1.10% | – |
| KYTH | New | KYTHERA BIOPHARMACEUTICALS I | $11,287,000 | – | 225,062 | +100.0% | 1.01% | – |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $11,025,000 | +56.0% | 265,205 | +0.4% | 0.99% | +28.6% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $10,981,000 | -37.8% | 1,077,642 | -14.9% | 0.99% | -48.7% |
| NVTA | New | INVITAE CORP | $10,946,000 | – | 785,131 | +100.0% | 0.98% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $10,855,000 | – | 119,114 | +100.0% | 0.98% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $9,451,000 | – | 796,900 | +100.0% | 0.85% | – |
| BLCM | Sell | BELLICUM PHARMACEUTICALS INC | $9,284,000 | -46.2% | 445,221 | -48.3% | 0.83% | -55.6% |
| NUVA | Sell | NUVASIVE INC | $8,514,000 | -49.7% | 185,137 | -48.4% | 0.76% | -58.5% |
| CERS | New | CERUS CORP | $6,871,000 | – | 1,647,727 | +100.0% | 0.62% | – |
| BIOS | New | BIOSCRIP INC | $6,105,000 | – | 1,378,200 | +100.0% | 0.55% | – |
| Buy | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $5,022,000 | +168.7% | 4,000,000 | +100.0% | 0.45% | +122.2% | |
| FLXN | Sell | FLEXION THERAPEUTICS INC | $4,270,000 | -32.9% | 189,624 | -39.8% | 0.38% | -44.7% |
| AKAOQ | Sell | ACHAOGEN INC | $3,888,000 | -59.4% | 398,340 | -45.7% | 0.35% | -66.5% |
| OTIC | New | OTONOMY INC | $2,792,000 | – | 78,972 | +100.0% | 0.25% | – |
| EBIO | ELEVEN BIOTHERAPEUTICS INC | $2,141,000 | -24.9% | 240,000 | 0.0% | 0.19% | -38.1% | |
| IHF | Buy | ISHARESus hlthcr pr etf | $1,144,000 | +286.5% | 8,599 | +244.0% | 0.10% | +221.9% |
| QQQ | Buy | POWERSHARES QQQ TRUSTunit ser 1 | $454,000 | +27.9% | 4,300 | +25.2% | 0.04% | +5.1% |
| PPH | MARKET VECTORS ETF TRpharmaceutical | $457,000 | +9.3% | 6,500 | 0.0% | 0.04% | -10.9% | |
| ALXN | ALEXION PHARMACEUTICALS INC | $241,000 | -6.2% | 1,390 | 0.0% | 0.02% | -21.4% | |
| CCXI | New | CHEMOCENTRYX INC | $132,000 | – | 17,500 | +100.0% | 0.01% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| IBB | Exit | ISHARES TRnasdq biotec etf | $0 | – | -1,000 | -100.0% | -0.03% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -4,887 | -100.0% | -0.04% | – |
| FWP | Exit | FORWARD PHARMA A/Ssponsored adr | $0 | – | -25,235 | -100.0% | -0.06% | – |
| LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -137,681 | -100.0% | -0.18% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -237,977 | -100.0% | -0.20% | – |
| TKAI | Exit | TOKAI PHARMACEUTICALS INC | $0 | – | -215,139 | -100.0% | -0.34% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -264,942 | -100.0% | -0.72% | – |
| CNXR | Exit | CONNECTURE INC | $0 | – | -943,000 | -100.0% | -0.92% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -234,254 | -100.0% | -0.99% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -102,227 | -100.0% | -1.02% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -135,270 | -100.0% | -1.64% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -93,865 | -100.0% | -1.93% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -87,523 | -100.0% | -1.98% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -258,305 | -100.0% | -1.98% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -368,615 | -100.0% | -3.78% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -342,349 | -100.0% | -4.17% | – |
| RAD | Exit | RITE AID CORP | $0 | – | -6,038,734 | -100.0% | -4.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.